This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database.
Urinary cross-linked N-telopeptide of type I collagen biomarker for management of osteoporosis treatment. Lansdale: HAYES, Inc.. 2010
Urinary cross-linked N-telopeptide of type collagen (NTx) is a biochemical marker of bone resorption. Urinary NTx can be measured noninvasively in the urine, and serum NTx can be quantified from blood. Urinary NTx has been recently proposed as an independent or complementary tool to bone mineral density (BMD) measures to identify bone loss, assess efficacy of osteoporosis treatment, predict fracture risk, and to enhance adherence to osteoporosis treatment.
Subject indexing assigned by CRD
Biomarkers; Bone Density; Collagen Type Is; Osteoporosis; Peptides
Country of organisation
An English language summary is available.
Address for correspondence
HAYES, Inc., 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218 Email: firstname.lastname@example.org
Date abstract record published